FKBP4 and neoplasm: To further validate the in vitro cell line data procured so far, LNCaP‐ID4 cells were subcutaneously injected into the flanks of 4‐week‐old previously castrated male SCID mice to investigate the effect of inhibiting FKBP52‐AR signaling on the tumor growth via MJC13 drug treatments.